ZBD(SH:603567) Zheng Quan Ri Bao·2025-09-19 23:14Core Viewpoint - The report outlines a reduction in the shareholding of Heilongjiang Chuangda Group Co., Ltd. in Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. due to the conversion of exchangeable bonds, resulting in a decrease in ownership from 60.85% to 59.87% [19][21]. Group 1: Shareholding Changes - The shareholding of Heilongjiang Chuangda Group decreased by 0.98% due to the conversion of 9,223,963 shares from the exchangeable bonds "23 Chuang 01 EB" and "23 Chuang 02 EB" [5][21]. - As of the report date, Heilongjiang Chuangda Group holds 563,334,314 shares, representing 59.87% of the total share capital of the company [19][21]. - The total shares converted from both exchangeable bonds amount to 16,550,986 shares, accounting for 1.76% of the total share capital [21]. Group 2: Future Plans and Compliance - Heilongjiang Chuangda Group has no plans to increase or decrease its shareholding in the next 12 months, aside from the ongoing conversion of the exchangeable bonds [4][21]. - The report confirms that the shareholding change does not trigger a mandatory tender offer and will not alter the status of the controlling shareholder or actual controller [19][22]. - The company has complied with all relevant laws and regulations regarding the disclosure of this shareholding change [22].